3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Arthritis, Rheumatoid
12
Spondylitis, Ankylosing
4
Psoriasis
2
Inflammatory Bowel Diseases
2
Thyroid Carcinoma, Anaplastic
1
Spondylarthritis
1
Sarcoidosis
1
Osteoarthritis
1
Nephrotic Syndrome
1
Nephrosis, Lipoid
1
Mucopolysaccharidosis VI
1
Mucopolysaccharidosis II
1
Mucopolysaccharidosis I
1
Mucopolysaccharidoses
1
Macular dystrophy, corneal type 1
1
Kidney Diseases
1
Joint Diseases
1
Inflammation
1
Infections
1
Glomerulosclerosis, Focal Segmental
1
Dupuytren Contracture
1
Crohn Disease
1
Colitis, Ulcerative
1
Autoimmune Diseases
1
Arthritis, Psoriatic
1
Arthritis
1
Interventions
World Health Organization oral rehydration solution
1
Vitamin D
1
Syringes
1
Nutrition Assessment
1
Injections, Intra-Articular
1
Fish Oils
1
Fatty Acids, Omega-3
1
Eicosapentaenoic Acid
1
Docosahexaenoic Acids
1
Cholecalciferol
1
Arthroplasty, Replacement, Shoulder
1
Arthroplasty, Replacement, Elbow
1
Adalimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Osteoarthritis
×
Adalimumab
×
Clear all
NCT00597623
2012-07-26
DORA
Assistance Publique - Hôpitaux de Paris
Phase 3
Completed
84 enrolled